跳至主要内容
临床试验/CTRI/2017/08/009489
CTRI/2017/08/009489已完成未知

Evalaution of Biomarker of Endothelial Dysfunction and on Glycemic Control with Herbochromium Supplement in Type 2 Diabetes mellitus patients

Dr C Uday Kumar0 个研究点目标入组 96 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.patients with fasting plasma glucose levels of 110-126 mg/dL 2.glycosylated haemoglobin (HbA1c) between 6.5 % and 8% 3. taking stable dose of anti-diabetic treatment (metformin 1500-2000 mg/day) for the past 8 weeks prior to the screening visit 4. those who have endothelial dysfunction defined as <= 6% change in reflection index (RI) on post salbutamol challenge test

排除标准

  • Patients with severe uncontrolled hyperglyceamia, uncontrolled hypertension, cardiac arrhythmia, impaired hepatic or renal function, history of malignancy or stroke, smoking, chronic alcoholism, any other serious disease requiring active treatment and treatment with any other herbal supplements, were excluded from the study.

研究者

发起方
Dr C Uday Kumar

相似试验

Evaluation of effect of chromium compounds on... | 临床试验